Related Experiment Video
Updated: Aug 22, 2026

MRI Mapping of Cerebrovascular Reactivity via Gas Inhalation Challenges
Published on: December 17, 2014
The cerebrovascular response to hypocapnia in children receiving propofol
Cengiz Karsli1, Igor Luginbuehl, Bruno Bissonnette
1From the Department of Anesthesia, The Hospital for Sick Children and the University of Toronto, Toronto, Ontario, Canada.
Insights
Hyperventilation to end-tidal carbon dioxide (ETco(2)) below 30 mm Hg does not further reduce cerebral blood flow velocity in children under propofol anesthesia. This suggests lower ETco(2) targets may not be necessary for managing intracranial pressure.
Area of Science:
- Pediatric Anesthesiology
- Neurocritical Care
- Cerebrovascular Physiology
Background:
- Hypocapnia is a strategy to reduce intracranial pressure (ICP) during neurosurgery.
- Cerebrovascular reactivity to carbon dioxide (CCO(2)R) is crucial for managing cerebral blood flow.
- Previous studies suggested a plateau in CCO(2)R below 35 mm Hg end-tidal carbon dioxide (ETco(2)) in children.
Purpose of the Study:
- To precisely define the relationship between ETco(2) and cerebral blood flow velocity (V(mca)) in children.
- To investigate the plateau effect of CCO(2)R at lower ETco(2) levels during propofol anesthesia.
- To determine the optimal ETco(2) threshold for achieving maximal reduction in V(mca) in pediatric patients.
Main Methods:
- Utilized transcranial Doppler (TCD) sonography to measure V(mca) in 27 healthy children.
- Adjusted ETco(2) in small increments (1-2 mm Hg) between 24 and 40 mm Hg.
- Administered standardized propofol infusion and caudal epidural block for anesthesia.
Main Results:
- An exponential relationship was observed between ETco(2) and V(mca) above 30 mm Hg (r = 0.82).
- V(mca) showed no significant change with ETco(2) levels below 30 mm Hg (r = 0.06).
- No significant alterations in heart rate or arterial blood pressure were noted.
Conclusions:
- Hyperventilation to ETco(2) below 30 mm Hg may not provide additional benefits in reducing cerebral blood flow velocity in children receiving propofol.
- Current recommendations for managing intracranial pressure via hyperventilation in this population may be reconsidered.
- Findings suggest that targeting ETco(2) values above 30 mm Hg is sufficient for achieving maximal cerebrovascular effects under propofol anesthesia in children.
Abstract:
Hypocapnia is used to treat acute increases in intracranial pressure during neurosurgery. Cerebrovascular reactivity to carbon dioxide (CCO(2)R) is preserved above 35 mm Hg ETco(2) in children during propofol anesthesia; however, a plateau effect has been suggested below 35 mm Hg. To further delineate this phenomenon, we measured CCO(2)R by transcranial Doppler (TCD) sonography over small increments in ETco(2) in 27 healthy children. Anesthesia comprised a standardized propofol infusion and a caudal epidural block. A TCD probe was placed to measure middle cerebral artery blood flow velocity (V(mca)). ETco(2) was adjusted between 24 and 40 mm Hg at 1-2 mm Hg increments using an exogenous source of CO(2). There was an exponential relationship between ETco(2) and V(mca) above an ETco(2) value of 30 mm Hg (r = 0.82). However, V(mca) did not change with ETco(2) less than 30 mm Hg (r = 0.06). There were no significant changes in heart rate or arterial blood pressure. We conclude that when contemplating methods to decrease brain volume and intracranial pressure, hyperventilation to ETco(2) values less than 30 mm Hg may not be necessary in children receiving propofol, as no further reduction in cerebral blood flow velocity will be achieved.
Related Concept Videos
Hyperpnea and Hyperventilation
Assessment of Diffusion and Perfusion
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this principle...
Parenteral Anesthetics: Overview
Chemical Factors Affecting Respiration Centers
CO2 has a potent influence on respiration and is strictly regulated. Under...
Inhalational Anesthetics: Overview
Acute Respiratory Failure-III
